The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest bipolar disorder therapeutics market share, and Europe was the fastest-growing region in 2022.

The global bipolar disorder therapeutics market is expected to grow from $6.51 billion in 2022 to $6.93 billion in 2023 at a compound annual growth rate (CAGR) of 6.5%. The bipolar disorder therapeutics market size is expected to grow to $8.36 billion in 2027 at a CAGR of 4.8%.

Major Driver In The Bipolar Disorder Therapeutics Market ­– Increase In The Prevalence Of Bipolar Disorder
According to the Depression and Bipolar Support Alliance, a non-profit organisation based in the United States that provides support to patients suffering from depression or bipolar disorder, approximately 5.7 million adult Americans, or about 2.6% of the U.S. population, will be affected by bipolar disorder in 2021. The usual age of beginning of bipolar disorder is 25 years, and more than two-thirds of people with the condition have at least one relative who has the illness.  As a result, the rising frequency of bipolar disorder is propelling the bipolar disorder treatments market forward.

View More On The Bipolar Disorder Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report

Key Bipolar Disorder Therapeutics Market Segments
1) By Drug Class: Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs
2) By Mechanism: Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Recent Bipolar Disorder Therapeutics Market Trend – Strategic Partnerships
Partnerships are being pursued by major firms in the bipolar disorder medicines sector in order to strengthen their position. Mindpax Inc., a Germany-based digital technology firm participating in the bipolar disorder therapeutics industry, for example, teamed with Eversana Life Science Services LLC, a US-based life sciences company operating in the bipolar disorder therapeutics market, in October 2021. Both firms will collaborate to produce remote clinical evaluations and targeted digital therapy to enhance patients’ clinical conditions and give personalised therapeutic interventions to bipolar patients as part of this collaboration. Furthermore, in November 2020, Biogen, a biotechnology company located in the United States, teamed with Sage Therapeutics, a startup based in the United States that develops innovative medications such as bipolar. Through this collaboration, both companies will collaborate to commercialise zuranolone (SAGE-217) for substantial postpartum depression (PPD), major depressive disorder (MDD), and other conditions.

Bipolar Disorder Therapeutics Market Prominent Players
Major players in the bipolar disorder therapeutics market are AbbVie Inc., Pfizer Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC, Januaryssen Pharmaceuticals, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Validus Pharmaceuticals, Eli Lilly and Company, Gedeon Richter PLC., Sumitomo Pharma Co. Ltd., and H. Lundbeck A/S.

Request A Sample Of The Global Bipolar Disorder Therapeutics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6736&type=smp

The Bipolar Disorder Therapeutics Global Market Report 2023  provides a comprehensive overview on the bipolar disorder therapeutics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the bipolar disorder therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Bipolar disorder therapies include medication to regulate symptoms such as mood stabilisers, antidepressants, antipsychotics, and psychological counselling. Bipolar disorder therapeutics are used to treat and manage bipolar disorders.

View More Related Reports –
Insulated Gate Bipolar Transistor IGBT Global Market Report 2023
Neurodegenerative Disorder Therapeutics Global Market Report 2023
Leukemia Therapeutics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model